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Purpose: To assess predictors of reverse remodeling by using car-
diac magnetic resonance (MR) imaging soon after ST-seg-
ment–elevation myocardial infarction (STEMI).
Materials and 
Methods:
Written informed consent was obtained from all patients, 
and the study protocol was approved by the institutional 
committee on human research, ensuring that it conformed 
to the ethical guidelines of the 1975 Declaration of Hel-
sinki. Five hundred seven patients (mean age, 58 years; 
age range, 24–89 years) with a first STEMI were prospec-
tively studied. Infarct size and microvascular obstruction 
(MVO) were quantified at late gadolinium-enhanced im-
aging. Reverse remodeling was defined as a decrease in 
left ventricular (LV) end-systolic volume index (LVESVI) of 
more than 10% from 1 week to 6 months after STEMI. For 
statistical analysis, a simple (from a clinical perspective) 
multiple regression model preanalyzing infarct size and 
MVO were applied via univariate receiver operating char-
acteristic techniques.
Results: Patients with reverse remodeling (n = 211, 42%) had a 
lesser extent (percentage of LV mass) of 1-week infarct 
size (mean 6 standard deviation: 18% 6 13 vs 23% 6 
14) and MVO (median, 0% vs 0%; interquartile range, 
0%–1% vs 0%–4%) than those without reverse remodel-
ing (n = 296, 58%) (P , .001 in pairwise comparisons). 
The independent predictors of reverse remodeling were 
infarct size (odds ratio, 0.98; 95% confidence interval 
[CI]: 0.97, 0.99; P = .04) and MVO (odds ratio, 0.92; 
95% CI: 0.86, 0.99; P = .03). Once infarct size and MVO 
were dichotomized by using univariate receiver operating 
characteristic techniques, the only independent predictor 
of reverse remodeling was the presence of simultaneous 
nonextensive infarct-size MVO (infarct size , 30% of LV 
mass and MVO , 2.5% of LV mass) (odds ratio, 3.2; 95% 
CI: 1.8, 5.7; P , .001).
Conclusion: Assessment of infarct size and MVO with cardiac MR im-
aging soon after STEMI enables one to make a decision in 
the prediction of reverse remodeling.
q RSNA, 2015
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to cardiac MR imaging. From January 
2008 to December 2010, 507 patients 
were prospectively included (Fig 1).
All patients gave written informed 
consent. The study protocol was ap-
proved by the institutional committee 
on human research in our institution 
and conforms to the ethical guidelines 
of the 1975 Declaration of Helsinki.
In all patients, clinical and angio-
graphic characteristics were regis-
tered upon admission. Patients were 
managed by a specific STEMI unit 
both in the hospital and after dis-
charge, and current recommendations 
were strictly followed (15,16). Base-
line characteristics of the entire study 
group and of patients both with and 
without reverse remodeling are shown 
in Table E1 (online).
Cardiac MR Imaging
All patients were examined with a 
1.5-T MR imaging system (Sonata 
Magnetom; Siemens, Erlangen, Ger-
many) according to our study pro-
tocol. Images were acquired with 
the use of a phased-array body 
surface coil, breath holding, and 
to assess predictors of reverse remod-
eling by performing cardiac MR imag-
ing soon after STEMI.
Materials and Methods
Patients
This study stems from an ongoing pro-
spective registry carried out in a uni-
versity hospital (12,13). Patients were 
considered for inclusion in the study 
group if they were admitted for a first 
STEMI that was defined according to 
current definitions, treated with PCI 
within 12 hours of chest pain onset, 
and underwent cardiac MR imaging 1 
week and 6 months after STEMI (14). 
We discarded the presence of a prior 
myocardial infarction on the basis of 
the absence of any previous admis-
sions due to cardiovascular diseases 
and by the absence of electrocardio-
graphic abnormalities, which suggest 
prior myocardial infarction. Exclusion 
criteria were death, reinfarction, or 
clinical instability at cardiac MR imag-
ing performed 1 week or 6 months af-
ter STEMI, as well as incomplete car-
diac MR imaging studies, insufficient 
image quality, and contraindications 
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MACE = major adverse cardiac events
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STEMI = ST-segment–elevation myocardial infarction
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Advance in Knowledge
 n This large prospective registry of 
patients with a first ST-segment–
elevation myocardial infarction 
(STEMI) treated with percuta-
neous coronary intervention 
shows that the detection of si-
multaneous nonextensive infarct 
size and microvascular obstruc-
tion at cardiac MR imaging per-
formed 1 week after infarction is 
decisive in predicting reverse 
remodeling during the following 
6 months.
Implications for Patient Care
 n The information derived from 
cardiac MR imaging performed 1 
week after a first STEMI relates 
to the occurrence of reverse 
remodeling during the following 
6 months.
 n Reverse remodeling of the left 
ventricle (LV) can be predicted 
by using the presence of simulta-
neous nonextensive infarct size 
(,30% of LV mass) and nonex-
tensive microvascular obstruction 
(,2.5% of LV mass) at late gad-
olinium-enhanced imaging per-
formed 1 week after infarction; 
this result was derived from a 
multiple logistic regression model 
in which the two independent 
variables were dichotomized by 
preanalyzing the data with uni-
variate receiver operating char-
acteristic techniques.
Left ventricular (LV) remodeling can occur in a wide variety of abnormal conditions associated 
with heart failure, and the course and 
clinical implications of this process 
have been extensively analyzed (1,2). 
The term LV reverse remodeling 
(hereafter referred to as reverse re-
modeling) refers to the concept that 
the failing heart is capable of under-
going favorable changes in LV volume 
and mass as a consequence of med-
ical, device-based, and surgical in-
terventions and reassuming a more 
normal and energetically favorable 
elliptical shape (1,3–5). Interestingly, 
most of these clinical studies have re-
ported that reverse remodeling is as-
sociated with an improvement in pa-
tient outcome (5–8).
ST-segment–elevation myocardial 
infarction (STEMI) has become one of 
the main causes of heart failure (9). 
Cardiac magnetic resonance (MR) im-
aging, including parameters that were 
recently shown to be crucial to patient 
outcome—namely, infarct size and mi-
crovascular obstruction (MVO) —has 
become the reference standard nonin-
vasive imaging technique for compre-
hensive assessment of patients with 
STEMI, (10,11). So far, no study spe-
cifically designed to address reverse 
remodeling after STEMI at cardiac 
MR imaging has been reported. Our 
hypothesis was that a simultaneous 
assessment of infarct size and MVO 
as derived from cardiac MR imaging 
can help predict reverse remodeling 
after STEMI. In this study, we aimed 
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higher than 5 standard deviations 
above that of a remote noninfarcted 
area in the same section. Subse-
quently, areas with late gadolinium en-
hancement were visually revised and 
quantified with manual planimetry. In-
farct size was assessed as the percent-
age of LV mass with late gadolinium 
enhancement. MVO was quantified 
with manual planimetry and defined as 
the percentage of LV mass with a lack 
of contrast material uptake in the core 
of tissue with late gadolinium enhance-
ment (11–13).
Myocardial edema was regarded 
as areas of high signal intensity on T2-
weighted images. A core of low signal 
intensity surrounded by an area with 
high signal intensity was considered 
to indicate myocardial hemorrhage. In 
each study, for quantification of all sec-
tions, only one of the two T2-weighted 
sequences performed (that with the 
highest image quality) was used to ana-
lyze edema and hemorrhage. All short-
axis sections were separately analyzed, 
and the presence of signal intensity 
higher than 2 standard deviations above 
that of a remote noninfarcted area in 
the same section was considered to in-
dicate edema. Then, myocardial edema 
and myocardial hemorrhage were man-
ually revised and expressed as percent-
age of LV mass. The myocardial salvage 
index was calculated by subtracting the 
mass of infarcted myocardium from 
myocardium showing edema and ex-
pressed as percentage of LV mass with 
myocardial edema (10,11).
Black-blood, T2-weighted, and 
short TI inversion recovery sequences 
were performed in mid diastole in the 
same short-axis view as the cine se-
quences. A half-Fourier acquisition 
single-shot turbo spin-echo multisec-
tion sequence was used (recovery 
time, 2 R-R intervals; echo time, 33 
msec, inversion time, 170 msec; sec-
tion thickness, 8 mm; section inter-
val, 2 mm; flip angle, 160°; matrix, 
256 3 151; bandwidth, 781 Hz/pixel). 
Additionally, a segmented turbo spin-
echo sequence was performed with 
one section per breath hold (recovery 
time, 2 R-R intervals; echo time, 100 
msec; inversion time, 170 msec; sec-
tion thickness, 8 mm; section inter-
val, 2 mm; flip angle, 180°; matrix, 
256 3 146; bandwidth, 235 Hz/pixel). 
LV ejection fraction (LVEF), LV end-
diastolic volume index (LVEDVI), LV 
end-systolic volume index (LVESVI), 
and LV mass were calculated with 
manual planimetry of endocardial and 
epicardial borders on short-axis cine 
images.
On the basis of recent literature, 
reverse remodeling was defined as 
a decrease in LVESVI of more than 
10% on cardiac MR images obtained 
1 week and 6 months after STEMI 
(3,17,18). This cut-off value was more 
than twice the mean intraobserver 
variability (3%) that we detected for 
LVESVI in the reproducibility test 
(Table E2 [online]).
Initially, late gadolinium enhance-
ment was regarded as signal intensity 
electrocardiographic triggering. In all 
studies, images were acquired by two 
cardiologists (M.P.L.L. and J.V.M., 
both with 15 years of experience) who 
specialized in cardiac MR imaging. 
Then, studies were quantified offline 
by a third operator (F.C., with 8 years 
of experience), who was blinded to 
all patient data, by using customized 
software (QMASS MR 6.1.5; Medis, 
Leiden, the Netherlands). Inter- and 
intraobserver variability for calculat-
ing all cardiac MR imaging indexes 
used in the present study are report-
ed in Table E2 (online). Cardiac MR 
imaging data were prospectively and 
immediately included in the registry 
database.
Cine images were acquired in two-, 
three-, and four-chamber and short-
axis views by using a steady-state 
free precession sequence (repetition 
time msec/echo time msec, 25/1.6; 
flip angle, 61°; matrix, 256 3 256, 
field of view, 320 3 270 mm, section 
thickness, 7 mm). Late gadolinium 
contrast material–enhanced imaging 
was performed 10–15 minutes after 
administering 0.1 mmol/kg of gado-
linium diethylenetriamine pentaacetic 
acid (Magnograf; Juste S.A.Q.F., Ma-
drid, Spain) in the same locations as 
in cine imaging by using a segmented 
inversion recovery steady-state free 
precession sequence (750/1.26; flip 
angle, 45°; matrix, 256 3 184; field 
of view, 340 3 235 mm, section thick-
ness, 7 mm). Inversion time was ad-
justed to nullify healthy myocardium.
Figure 1
Figure 1: Flowchart shows the reasons patients were excluded from the study.
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Results
Of 691 patients with STEMI who were 
consecutively admitted to our institu-
tion between January 2008 and De-
cember 2010 and treated with PCI 
within the first 12 hours after chest 
pain onset, 184 were excluded due to 
death, reinfarction, clinical instabil-
ity, claustrophobia, contraindications 
to cardiac MR imaging, incomplete 
cardiac MR imaging studies, or insuf-
ficient image quality before cardiac 
MR imaging performed 1 week or 6 
months after STEMI (Fig 1). Thus, 
the final study group comprised 507 
patients who were successfully evalu-
ated with cardiac MR imaging 1 week 
and 6 months after STEMI (Fig 1). 
The mean age was 58 years (range, 
24–89). Women (n = 81; mean age, 64 
years; age range, 31–86 years) were 
significantly older (P , .001) than 
men (n = 426; mean age, 57 years; 
age range, 24–89 years). Baseline and 
cardiac MR imaging characteristics 
are shown in Table E1 (online).
Incidence and Structural Consequences  
of Reverse Remodeling
Reverse remodeling (.10% decrease 
in LVESVI at 6 months) occurred in 
211 patients (42%). Baseline charac-
teristics of patients with and without 
reverse remodeling are shown in Table 
E1 (online), and dynamic changes in 
cardiac MR imaging indexes from 1 
week to 6 months in the whole study 
group are shown in Table E3 (online).
From 1 week to 6 months, a 25% 
(range, 221% to 11%) reduction in 
LVESVI occurred in the entire study 
group. Patients with reverse remod-
eling showed a decrease in LVESVI 
of 225% (range, 235% to 218%), 
whereas the opposite (4%; range, 
23% to 20%) was seen in those with-
out reverse remodeling; P , .001.
In patients with reverse remod-
eling, from 1 week to 6 months, 
LVEDVI and LVESVI diminished, 
whereas LVEF increased (P , .001 
for all pairwise comparisons). Con-
versely, patients without reverse re-
modeling exhibited substantial di-
lation of LVEDVI and LVESVI, as 
regression procedures were tested and 
adjusted by baseline, angiographic, 
and cardiac MR imaging variables, 
yielding P , .2 in univariate analyses. 
Odds ratios with the respective 95% 
confidence intervals were computed. 
Two analyses were used in this arti-
cle: First, multiple logistic regression 
was performed, in which all variables 
were used as predictors and all con-
tinuous variables were treated as con-
tinuous. Infarct size and MVO (tested 
as continuous variables) were the in-
dependent predictors in the forward, 
backward, and forward-backward 
stepwise multiple logistic regression 
procedures. Then, a simpler (from a 
clinical perspective) multiple logistic 
regression model was proposed by di-
chotomizing infarct size and MVO via 
univariate receiver operating char-
acteristics curve (ROC) techniques. 
Once the best cut-off values of infarct 
size (considered extensive if more 
than 30% of LV mass) and MVO (con-
sidered extensive if more than 2.5% 
of LV mass) for predicting reverse re-
modeling were obtained, nonoverlap-
ping patients were categorized as hav-
ing simultaneous nonextensive infarct 
size and MVO, extensive MVO and 
nonextensive infarct size, extensive 
infarct size and nonextensive MVO, 
or simultaneous extensive infarct size 
and MVO. The in-sample predictive 
value of these categories to predict 
reverse remodeling in univariate and 
multiple regression analyses was as-
sessed. The association of these cate-
gories with the state of LVEF, LVEDVI, 
and LV mass at cardiac MR imaging 
performed 6 months after STEMI was 
also investigated.
The final forward, backward, and 
forward-backward multiple regression 
models yielded the same independent 
predictors of reverse remodeling both 
when continuous variables were treated 
as continuous and when infarct size and 
MVO were dichotomized. Data shown 
throughout this article refer to the for-
ward multiple regression models. A 
two-tailed P , .05 was considered to 
indicate a significant difference. The 
SPSS statistical package (version 18.0; 
SPSS, Chicago, Ill) was used.
End Points and Follow-up
The end points of the present study 
were to analyze the incidence of 
reverse remodeling and its predictors 
at cardiac MR imaging performed 1 
week after STEMI in a prospective 
series of patients with a first STEMI. 
We explored the association between 
the occurrence of reverse remodel-
ing and major adverse cardiac events 
(MACE), a composite of cardiac death, 
nonfatal myocardial infarction, and re-
admission for heart failure (whichever 
occurred first), according to current 
recommendations (14,19). To adjudi-
cate an event, consensus between two 
cardiologists was required.
Statistical Analysis
Data were tested for normal distribution 
by using the Kolmogorov-Smirnov test. 
Continuous normally distributed data 
were expressed as the mean plus or 
minus the standard deviation of the 
mean and compared by using the un-
paired or paired samples Student t test 
where appropriate. The analysis of var-
iance test (P for the trend) was used to 
compare more than two groups. Non-
parametric data were expressed as the 
median with the interquartile range and 
compared by using the Mann-Whitney 
U test. Group percentages were com-
pared by using the x2 test or Fisher ex-
act test where appropriate. P for the 
trend was used to compare more than 
two percentages.
The association of reverse re-
modeling with time to MACE was 
assessed with Kaplan-Meier curves 
and the log-rank test. Patients were 
censored from the survival analysis 
at the moment of the first MACE (ie, 
cardiac death, nonfatal myocardial 
infarction, or readmission for heart 
failure), at the moment they were lost 
to follow-up, or 5 years after the in-
clusion of the first patient in the study 
group. Patients were included in the 
survival analysis until they reached 
any of the reasons for censorship, at 
which point they were excluded from 
this test.
To predict reverse remodeling, 
forward, backward, and forward-
backward stepwise multiple logistic 
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with nonextensive infarct size and 
MVO (35 mL/m2 6 15 vs 31 mL/m2 
6 13; P , .001), did not vary in those 
with extensive MVO and nonextensive 
infarct size (42 mL/m2 6 11 vs 41 mL/
m2 6 11, P = .7) or extensive infarct 
size and nonextensive MVO (54 mL/m2 
6 26 vs 56 mL/m2 6 28; P = .5), and 
dilated in patients with extensive in-
farct size and MVO (59 mL/m2 6 21 vs 
65 mL/m2 6 27; P = .004) (Figs 2, 3).
range, 0.54–0.64). Simultaneous non-
extensive infarct size and MVO oc-
curred in 336 patients (66%), exten-
sive MVO and nonextensive infarct size 
occurred in 56 (11%), extensive infarct 
size and nonextensive MVO occurred 
in 42 (8%), and simultaneous exten-
sive infarct size and MVO occurred in 
73 (15%).
From 1 week to 6 months after 
STEMI, LVESVI diminished in patients 
well as deterioration of LVEF (P , 
.001 for all pairwise comparisons) 
(Table 1).
Cardiac MR Imaging Predictors of 
Reverse Remodeling
The magnitude of LV dilation and sys-
tolic dysfunction soon after infarction 
was not associated with reverse re-
modeling; no significant differences in 
terms of LVEDVI, LVESVI, LV mass, or 
LVEF were observed between patients 
with and those without reverse remod-
eling at 1-week cardiac MR imaging. 
Nevertheless, compared with patients 
without reverse remodeling, those with 
reverse remodeling displayed a much 
less extensive infarct size and MVO 1 
week after infarction (P , .001) (Fig 
E1 [online]). Less edema and hemor-
rhage (P , .05) and a trend toward 
more myocardial salvage index (P , .1) 
were detected at 1-week cardiac MR 
imaging in the case of reverse remodel-
ing (Fig E1 [online]).
In the multiple regression analysis, 
once adjustments for baseline and 
cardiac MR imaging characteristics 
showing an association (P , .2) with 
reverse remodeling in the univariate 
analysis (ie, age, male sex, diabetes 
mellitus, anterior infarction, throm-
bolysis in myocardial infarction flow 
grade before PCI, edema, hemor-
rhage, myocardial salvage index, in-
farct size, and MVO) were made, 
the only independent predictors of 
reverse remodeling were infarct size 
(0.98; range, 0.97–0.99; P = .04) and 
MVO (0.92; range, 0.86–0.99; P = 
.03) (Table 2).
Combined Role of infarct size and MVO at 
Reverse Remodeling
More extensive infarct size and MVO 
were independently associated with a 
lower probability of reverse remodel-
ing. The independent variables (ie, 
infarct size and MVO) were dichot-
omized as extensive (infarct size . 
30% of LV mass and MVO . 2.5% of 
LV mass) or nonextensive as derived 
from the best cut-off values to pre-
dict reverse remodeling on the basis 
of their respective ROCs (infarct size, 
0.61; range, 0.56–0.68; MVO, 0.59; 
Table 1
Evolution of LVEF, Volumes Indexes, and Mass from the First Week to the Sixth Month 
in Patients with and without Reverse Remodeling
Characteristic
With Reverse Remodeling 
(n = 211)
Without Reverse Remodeling 
(n = 296)
1 Week 6 Months P Value 1 Week 6 Months P Value
LVEF (%) 51 6 12 59 6 11 ,.001 50 6 12 50 6 13 .9
LVEDVI (mL/m2) 81 6 18 71 6 17 ,.001 78 6 23 88 6 24 ,.001
LVESVI (mL/m2) 41 6 17 30 6 13 ,.001 40 6 20 46 6 23 ,.001
LV mass (g/m2) 70 6 15 64 6 13 ,.001 71 6 18 68 6 16 .001
Note.—Unless otherwise indicated, data are the means plus or minus standard deviation.
Table 2
Predictors of Reverse Remodeling at Multiple Regression Analyses
Predictor Odds Ratio P Value
Age (y) 1.01 (0.99, 1.03 .3
Male sex (%) 0.7 (0.40, 1.40) .3
Diabetes mellitus 0.69 (0.38, 1.27) .2
Anterior infarction (%) 1.13 (0.68, 1.88) .6
TIMI flow grade before PCI 1.00 (0.85, 1.18) .9
Edema (% of LV mass) 1.00 (0.95, 1.05) .9
Hemorrhage (% of LV mass) 1.00 (0.91, 1.11) .9
Myocardial salvage index (%) 1.00 (0.98, 1.02) .8
MVO (% of LV mass) 0.92 (0.86, 0.99) .03
IS (% of LV mass) 0.98 (0.97, 0.99) .04
Categories of IS and MVO
 Simultaneous extensive IS and MVO … …
 Extensive IS and nonextensive MVO 1.65 (0.71, 3.82) .2
 Extensive MVO and nonextensive IS 1.20 (0.54, 2.69) .6
 Simultaneous nonextensive IS and MVO 3.18 (1.77, 5.70) ,.001
Note.—Data in parentheses are 95% confidence intervals. Variables that yielded a P value off less than .2 at univariate analyses 
(age, male sex, diabetes mellitus, anterior infarction, TIMI flow grade before PCI, edema, hemorrhage, myocardial salvage index, 
MVO, and infarct size) were tested (Table E1 and Fig E1 [online]). All cardiac MR imaging variables (ie, edema, hemorrhage, 
myocardial salvage index, MVO, and infarct size) were tested as continuous variables. The independent variables (ie, infarct size 
and MVO) were dichotomized according to their best cut-off values for predicting reverse remodeling on the basis of their 
respective univariate ROCs (extensive infarct size if . 30% of LV mass and extensive MVO if . 2.5% of LV mass). Simultaneous 
extensive infarct size and MVO is used as the reference category for comparisons. IS = infarct size, TIMI = thrombolysis in 
myocardial infarction.
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range, 1.77–5.70; P , .001) (Table 2). 
A steady deterioration in ejection 
fraction and dilation in LVESVI, 
LVEDVI, and LV mass at 6 months af-
ter STEMI was detected along the four 
categories of infarct size and MVO 
(Fig 4).
Reverse Remodeling and MACE
During a mean follow-up period of 186 
weeks 6 113 (range, 12–250 weeks), 
56 first MACE took place, including 12 
deaths, 21 reinfarctions, and 23 re-
admissions for heart failure. Reverse 
remodeling showed a nonsignificant 
trend toward a lower probability of 
MACE occurring during the follow-up 
period (16 of 211 [7%] vs 40 of 296 
[13%]; P = .055) (Fig 5).
Discussion
The main findings of the present study 
were as follows: (a) in a large prospec-
tive series of patients with a first STE-
MI treated with PCI, sequential cardiac 
MR imaging depicted reverse remodel-
ing in almost one-half of cases and (b) 
late gadolinium-enhanced imaging con-
tributes the most relevant information 
in the prediction of reverse remodeling. 
The presence of simultaneous nonex-
tensive infarct size and nonextensive 
MVO at 1-week cardiac MR imaging 
predicted the occurrence of reverse re-
modeling to best advantage.
Incidence and Structural Consequences of 
Reverse Remodeling after STEMI
Little information is available on 
reverse remodeling after STEMI. Only 
three studies, all of which are based 
on echocardiography, have specifically 
addressed this issue (17,18,20). So 
far, there have been no reports analyz-
ing the incidence, consequences, and 
prediction of reverse remodeling with 
cardiac MR imaging in patients with 
STEMI.
A significant decrease of LVESVI 
(. 10% at 6-month cardiac MR imag-
ing) was detected in almost one-half 
(42%) of patients in our prospective 
study of 507 patients. Reverse re-
modeling was not futile in terms of 
structural consequences on the LV: 
infarct size and MVO (P , .001 for 
the trend) (Fig 2). When these four 
categories of infarct size and MVO 
were incorporated into the multiple 
regression analysis, the presence of 
nonextensive infarct size and MVO 
appeared as the only independent 
predictor of reverse remodeling (3.18; 
Reverse remodeling occurred in 
165 of 336 patients (49%) with nonex-
tensive infarct size and MVO, 15 of 56 
patients (27%) with extensive MVO 
and nonextensive infarct size, 14 of 42 
patients (33%) with extensive infarct 
size and nonextensive MVO, and 17 
of 73 patients (23%) with extensive 
Figure 2
Figure 2: Graphs show the occurrence and course of reverse remodeling 
(RevRem) according to the magnitude of infarct size (IS) and MVO at 1-week 
cardiac MR imaging. The independent variables, infarct size, and MVO were 
dichotomized as extensive (infarct size . 30% of LV mass and MVO . 2.5% 
of LV mass) or nonextensive as derived from the best cut-off values to predict 
reverse remodeling on the basis of their respective univariate ROCs. The oc-
currence of reverse remodeling was highest in patients with simultaneous non-
extensive infarct size and MVO (top). Lower panel: From 1 week to 6 months, 
LVESVI diminished in patients with simultaneous nonextensive infarct size and 
MVO, did not vary in those with extensive MVO and nonextensive infarct size 
or extensive infarct size and nonextensive MVO, and dilated in patients with 
simultaneous extensive infarct size and MVO (bottom). 
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Predictors of Reverse Remodeling after 
STEMI
The magnitude of LV dilatation and 
systolic dysfunction 1 week after in-
farction did not relate to subsequent 
reverse remodeling. This implies that, 
even in patients with severely altered 
LV volumes or ejection fraction soon 
after STEMI, a substantial reduction 
of LVESVI cannot be dismissed. Thus, 
the state of LV volumes and LVEF be-
fore discharge is not enough to predict 
reverse remodeling.
Reverse remodeling is associated, 
to a lesser extent, with edema, hem-
orrhage, infarct size, and MVO and a 
trend toward a bigger myocardial sal-
vage index. In a first multiple regres-
sion approach in which all continuous 
variables were treated as continuous, 
MVO and infarct size were the inde-
pendent predictors of reverse remod-
eling. Then, a simpler multiple regres-
sion model dichotomizing infarct size 
and MVO (extensive vs nonextensive) 
via univariate ROC techniques revealed 
that, from a clinical perspective, the 
main predictor of reverse remodeling 
was the presence of simultaneous non-
extensive infarct size and MVO. From 
1-week to 6-month cardiac MR imag-
ing, a substantial decrease in LVESVI 
was detected in only the patients with 
simultaneous nonextensive MVO (, 
2.5% of LV mass) and infarct size (, 
30% of LV mass). Thus, for reverse 
remodeling to take place, myocardial 
and microvascular integrity must be 
preserved (or not severely altered). 
Late gadolinium enhancement imaging 
represents an excellent tool for assess-
ing these parameters and predicting 
reverse remodeling.
After STEMI, the extent of hemor-
rhage and MVO are closely related. In 
our results, patients with reverse re-
modeling exhibited less extensive MVO 
and hemorrhage than did those with-
out reverse remodeling; however, only 
MVO was an independent predictor of 
reverse remodeling. Accurately mea-
suring hemorrhage is sometimes diffi-
cult; in fact, in the variability analyses, 
the MVO measurement was more re-
producible than that of hemorrhage, a 
fact that may explain why higher MVO 
this different course brought about a 
much bigger reduction in LV volumes 
and mass and a much more preserved 
LVEF at 6-month cardiac MR imaging 
in patients with reverse remodeling.
As expected, striking differences in 
terms of LVESVI variations were de-
tected between patients with (median, 
225%) and those without (median, 
4%) reverse remodeling. Interestingly, 
Figure 3
Figure 3: The four categories of infarct size (IS) and MVO and the typical course of LVESVI. Late 
gadolinium-enhanced (LGE) cardiac MR images obtained 1 week after STEMI (left column), short-axis 
cine MR images obtained 1 week after STEMI (middle column), and short-axis cine MR images obtained 
6 months after STEMI (right column) show the course of reverse remodeling according to the magni-
tude of infarct size and microvascular obstruction. Characteristically, LVESVI decreased in patients with 
simultaneous nonextensive infarct size and MVO (top row), did not vary in those with extensive MVO and 
nonextensive infarct size (second row) or extensive infarct size and nonextensive MVO (third row), dilated 
in patients with simultaneous extensive infarct size and MVO (bottom row). Arrowheads = MVO, dashed 
lines = infarct size.
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of simultaneous extensive infarct size 
and MVO soon after STEMI is strongly 
associated with a higher mortality rate 
within the following year. Thus, the 
presence of simultaneous nonextensive 
infarct size and MVO at late gadolini-
um-enhanced MR imaging seems to be 
beneficial both for promoting reverse 
remodeling and preventing cardiac 
events.
The analysis was performed in 
a single sample of patients, and the 
proposed models used thresholds 
derived from that same single sam-
ple (via a separate analysis). For this 
reason, the threshold results and the 
role of the newly found best prog-
nostic category for reverse remod-
eling may be nongeneralizable. An 
independent and broader separate 
reverse remodeling probably reflects 
that reverse remodeling is a multifac-
torial process, and further studies will 
be needed to better understand its 
pathophysiologic characteristics.
Regarding the clinical impact of 
reverse remodeling, our exploratory 
data indicate that, beyond its salu-
tary effects on LV performance, this 
process might portend benefits to pa-
tients with STEMI. Similar to two pre-
vious studies that used echocardiogra-
phy, the event rate almost halved in the 
group of patients with reverse remod-
eling (17,18). The prognostic utility of 
cardiac MR imaging soon after STEMI 
has already been validated and was not 
the primary objective of the present 
study (10–13,21). Recently, Eitel et al 
(10) demonstrated that the presence 
values predict reverse remodeling in 
the present study (Table E2 [online]). 
Moreover, in a recent multicenter 
study, MVO—and not hemorrhage—
was an independent prognosticator of 
cardiac events (10).
It should be emphasized that the 
categorization of the study group into 
four subgroups (simultaneous nonex-
tensive infarct size and MVO, exten-
sive MVO and nonextensive infarct 
size, extensive infarct size and non-
extensive MVO, and simultaneous ex-
tensive infarct size and MVO) on the 
basis of the best cut-off values for in-
farct size and MVO was not perfect 
for predicting reverse remodeling. 
The fact that a combined analysis of 
infarct size and MVO was insufficient 
to accurately predict the probability of 
Figure 4
Figure 4: State of LV indexes at cardiac MR imaging 6 months after STEMI according to the magnitude of infarct size (IS) and MVO at 1-week 
cardiac MR imaging. Graphs show a steady deterioration in LVEF (top left) and dilation in LVESVI (top right), LVEDVI (bottom left), and LV mass 
(bottom right) at 6 months in the four categories of MVO and infarct size.
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survival analysis the moment of the first MACE (n = 56), the moment they were 
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study group. At all time points, the number of patients at risk are shown at the foot 
of x-axis. Censored patients are shown on the survival curves.
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